[go: up one dir, main page]

MX2009004776A - Celulas madre mesenquimaticas derivadas de medula osea como una fuente de progenitores neurales. - Google Patents

Celulas madre mesenquimaticas derivadas de medula osea como una fuente de progenitores neurales.

Info

Publication number
MX2009004776A
MX2009004776A MX2009004776A MX2009004776A MX2009004776A MX 2009004776 A MX2009004776 A MX 2009004776A MX 2009004776 A MX2009004776 A MX 2009004776A MX 2009004776 A MX2009004776 A MX 2009004776A MX 2009004776 A MX2009004776 A MX 2009004776A
Authority
MX
Mexico
Prior art keywords
mesenchymal stem
source
stem cells
bone marrow
derived mesenchymal
Prior art date
Application number
MX2009004776A
Other languages
English (en)
Inventor
Saud A Sadiq
K Harris Violane
Original Assignee
Multiple Sclerosis Res Ct Of N
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Multiple Sclerosis Res Ct Of N filed Critical Multiple Sclerosis Res Ct Of N
Publication of MX2009004776A publication Critical patent/MX2009004776A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0622—Glial cells, e.g. astrocytes, oligodendrocytes; Schwann cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0619—Neurons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0623—Stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/13—Nerve growth factor [NGF]; Brain-derived neurotrophic factor [BDNF]; Cilliary neurotrophic factor [CNTF]; Glial-derived neurotrophic factor [GDNF]; Neurotrophins [NT]; Neuregulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/08—Coculture with; Conditioned medium produced by cells of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
    • C12N2506/1346—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells
    • C12N2506/1353—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells from bone marrow mesenchymal stem cells (BM-MSC)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Se proveen métodos para tratar y/o reducir la severidad de esclerosis múltiple en un humano, administrando precursores neurales derivados de células madre mesenquimáticas autólogas; se describe también un método in vitro para la diferenciación de tipos de células neuronales y oligodendrogliales de precursores neurales derivados de células madre mesenquimáticas.
MX2009004776A 2006-11-03 2007-11-02 Celulas madre mesenquimaticas derivadas de medula osea como una fuente de progenitores neurales. MX2009004776A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85651506P 2006-11-03 2006-11-03
PCT/US2007/023184 WO2008057443A2 (en) 2006-11-03 2007-11-02 Bone marrow-derived mesenchymal stem cells as a source of neural progenitors

Publications (1)

Publication Number Publication Date
MX2009004776A true MX2009004776A (es) 2009-07-14

Family

ID=39365076

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009004776A MX2009004776A (es) 2006-11-03 2007-11-02 Celulas madre mesenquimaticas derivadas de medula osea como una fuente de progenitores neurales.

Country Status (15)

Country Link
US (5) US8642331B2 (es)
EP (2) EP3031326A3 (es)
CA (1) CA2668200C (es)
CY (1) CY1120115T1 (es)
DK (1) DK2086332T3 (es)
ES (1) ES2663875T3 (es)
HR (1) HRP20180533T1 (es)
HU (1) HUE036745T2 (es)
LT (1) LT2086332T (es)
MX (1) MX2009004776A (es)
PL (1) PL2086332T3 (es)
PT (1) PT2086332T (es)
RS (1) RS57083B1 (es)
SI (1) SI2086332T1 (es)
WO (1) WO2008057443A2 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2009004776A (es) 2006-11-03 2009-07-14 Multiple Sclerosis Res Ct Of N Celulas madre mesenquimaticas derivadas de medula osea como una fuente de progenitores neurales.
US9301975B2 (en) 2009-05-01 2016-04-05 Biocardia, Inc. Method of preparing autologous cells and method of use for therapy
US20120020931A1 (en) 2010-06-02 2012-01-26 Rutgers, The State University Of New Jersey Therapeutic encapsulated embryonic stem cells and mesenchymal stromal cells
KR20190017065A (ko) 2010-08-18 2019-02-19 테레사 데이셔 림프양 조직에 줄기 세포와 조상 세포 결합을 저해하고, 그리고 림프 조직에서 배 중심을 재생하기 위한 조성물과 방법
EP2624845A4 (en) 2010-10-08 2015-09-09 Mesoblast Internat S Rl IMPROVED MSC PREPARATIONS
WO2012070964A1 (ru) * 2010-11-22 2012-05-31 Farber Boris Slavinovich Модифицированные олигопептиды с противораковыми свойствами и способ их получения
CA2926575C (en) 2013-10-14 2023-01-31 Hadasit Medical Research Services & Development Limited Method of obtaining terminally differentiated neuronal lineages and uses thereof
WO2015143074A1 (en) * 2014-03-20 2015-09-24 University Of Southern California Brain cancer immunotherapy
WO2016168993A1 (en) 2015-04-22 2016-10-27 Innolife Co., Ltd. Methods of tissue repair and regeneration
WO2016205371A1 (en) 2015-06-15 2016-12-22 Mayo Foundation For Medical Education And Research Using autologous mesenchymal stem cells to treat multiple system atrophy
AU2016335563B2 (en) 2015-10-08 2022-10-27 Neurona Therapeutics Inc. Neural precursor cell populations and uses thereof
EP3478300B1 (en) 2016-06-30 2022-08-24 Stem Cell Medicine Ltd. Treatment of inflammatory bowel disease with long acting glatiramer and adipose-derived stem cells
CN110573170A (zh) 2017-05-15 2019-12-13 干细胞医药有限公司 使用脂肪来源的干细胞治疗多发性硬化症
AU2017414803B2 (en) 2017-05-15 2025-02-13 Mapi Pharma Ltd. Treatment of multiple sclerosis with long acting glatiramer and adipose-derived stem cells
US12473547B2 (en) 2017-11-22 2025-11-18 Mesoblast International Sàrl Use of mesenchymal lineage precursor cells or stem cells (MLPSCs) for delivery of oligonucleotides in the treatment of cancer
WO2021020666A1 (en) * 2019-07-26 2021-02-04 Brexogen Inc. Precursor cells of induced pluripotent stem cell-derived mesenchymal stem cells and method for preparing the same
EP4004191A4 (en) 2019-07-26 2022-10-12 Brexogen Inc. Precursor cells of induced pluripotent stem cell-derived mesenchymal stem cells and method for preparing the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7037719B1 (en) * 1999-02-12 2006-05-02 Stemcells California, Inc. Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations
US8017112B2 (en) * 1999-05-14 2011-09-13 Henry Ford Health System Transplantation of bone marrow stromal cells for treatment of neurodegenerative diseases
US20040208858A1 (en) * 2000-04-12 2004-10-21 Gihan Tennekoon Therapeutic uses for mesenchymal stromal cells
CA2465653C (en) * 2001-10-30 2013-10-08 Renomedix Institute Inc. Method for inducing differentiation of mesodermal stem cells, es cells, or immortalized mesodermal stem cells into neural cells
DK1893747T3 (en) * 2005-06-16 2014-12-01 Univ Ramot ISOLATED CELLS AND POPULATIONS INCLUDING SUCH CELLS FOR TREATING CNS DISEASES
MX2009004776A (es) 2006-11-03 2009-07-14 Multiple Sclerosis Res Ct Of N Celulas madre mesenquimaticas derivadas de medula osea como una fuente de progenitores neurales.

Also Published As

Publication number Publication date
LT2086332T (lt) 2018-04-25
HRP20180533T1 (hr) 2018-05-18
US9657268B2 (en) 2017-05-23
US20140308745A1 (en) 2014-10-16
US20150064145A1 (en) 2015-03-05
US9328329B2 (en) 2016-05-03
HUE036745T2 (hu) 2018-07-30
EP3031326A3 (en) 2016-09-14
SI2086332T1 (en) 2018-06-29
PL2086332T3 (pl) 2018-07-31
US20110236357A1 (en) 2011-09-29
WO2008057443A3 (en) 2008-11-20
WO2008057443A9 (en) 2008-07-17
EP3031326A2 (en) 2016-06-15
ES2663875T3 (es) 2018-04-17
EP2086332B1 (en) 2018-01-10
CA2668200A1 (en) 2008-05-15
PT2086332T (pt) 2018-04-04
US8642331B2 (en) 2014-02-04
US20150118198A1 (en) 2015-04-30
CA2668200C (en) 2017-04-18
CY1120115T1 (el) 2018-12-12
EP2086332A4 (en) 2010-08-11
RS57083B1 (sr) 2018-06-29
WO2008057443A2 (en) 2008-05-15
EP2086332A2 (en) 2009-08-12
US20100166712A1 (en) 2010-07-01
DK2086332T3 (en) 2018-04-16

Similar Documents

Publication Publication Date Title
MX2009004776A (es) Celulas madre mesenquimaticas derivadas de medula osea como una fuente de progenitores neurales.
MX2009004238A (es) Metodos y composiciones para tratamiento de defectos oseos con poblaciones de celulas de placenta.
MY159971A (en) Multipotent/pluripotent cells and methods
EP4410991A3 (en) Differentiation of human embryonic stem cells
AU2017254264A1 (en) Method for producing retinal tissue
WO2007100692A3 (en) Method of generating human retinal progenitors from embryonic stem cells
SG170068A1 (en) Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production
PL2274419T3 (pl) Sposoby wytwarzania mikromieszków włosowych i brodawek de novo i stosowanie ich w badaniach in vitro i przeszczepach in vivo
MX339669B (es) Diferenciacion de celulas madres embrionarias humanas.
MX2008001709A (es) Produccion de celulas reprogramadas con potencial restablecido.
SG169324A1 (en) Differentiation of non-embryonic stem cells to cells having a pancreatic phenotype
WO2007136936A3 (en) Dermis-derived cells for tissue engineering applications
WO2003004605A3 (en) Mesenchymal cells and osteoblasts from human embryonic stem cell
WO2007080590A3 (en) Human embryonic stem cell-derived connective tissue progenitors for tissue engineering
MX2009007391A (es) Metodos para aumentar e inmovilizar células madre hematopoyéticas.
PH12014501175B1 (en) Medium composition for rejuvenating stem cells
EP3546568A3 (en) Differentiation of pluripotent stem cells and cardiac progenitor cells into striated cardiomyocyte fibers using laminins ln-511, ln-521 and ln-221
GB2453074A (en) Differentiation of primate pluripotent cells to hepatocyte-lineage cells
WO2011097242A3 (en) Methods of isolating and culturing mesenchymal stem cells
WO2008070258A3 (en) Directed differentiation of human embryonic stem cells into mesenchymal/stromal cells
WO2010065546A3 (en) MAINTENANCE/EXPANSION OF HSCs
WO2009151301A3 (ko) 인간배아줄기세포 유래 혈관전구세포를 이용한 창상 치료용 이식재 및 치료 방법
HK40088105A (en) Method for treating hyperinflammation using mesenchymal lineage precursor or stem cells
AU2020904312A0 (en) Method for treating hyperinflammation using mesenchymal lineage precursor or stem cells
AU2020903694A0 (en) Method for treating hyperinflammation using mesenchymal lineage precursor or stem cells

Legal Events

Date Code Title Description
FG Grant or registration